Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
US Department of Justice
Federal Trade Commission
Express Scripts
Boehringer Ingelheim
Fuji
Harvard Business School
McKinsey
Baxter

Generated: May 22, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 201464

« Back to Dashboard

Summary for 201464
Tradename:LEVETIRACETAM
Applicant:Pharmadax Inc
Ingredient:levetiracetam
Patents:0
Therapeutic Class:Anticonvulsants
Formulation / Manufacturing:see details
Pharmacology for NDA: 201464
Suppliers and Packaging for NDA: 201464
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
LEVETIRACETAM levetiracetam TABLET, EXTENDED RELEASE;ORAL 201464 ANDA Par Pharmaceutical 64376-697 N 64376-697-32
LEVETIRACETAM levetiracetam TABLET, EXTENDED RELEASE;ORAL 201464 ANDA Par Pharmaceutical 64376-697 N 64376-697-61

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET, EXTENDED RELEASE;ORALStrength500MG
Approval Date:May 25, 2012TE:ABRLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET, EXTENDED RELEASE;ORALStrength750MG
Approval Date:May 25, 2012TE:ABRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
UBS
AstraZeneca
Teva
Daiichi Sankyo
Medtronic
Citi
McKinsey
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.